Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,506 | -6,287 | -4,805 | -20,275 | -14,617 |
| Depreciation Amortization | 637 | 437 | 224 | 1,008 | 769 |
| Other Working Capital | -2,692 | -3,060 | -1,383 | 5,597 | 2,569 |
| Other Operating Activity | 591 | 339 | 171 | 698 | 541 |
| Operating Cash Flow | $-10,970 | $-8,571 | $-5,793 | $-12,972 | $-10,738 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -118 | -108 | -97 | -509 | -381 |
| Purchase Sale Intangibles | N/A | N/A | N/A | N/A | -117 |
| Other Investing Activity | 0 | 0 | 0 | -250 | -367 |
| Investing Cash Flow | $-118 | $-108 | $-97 | $-759 | $-748 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -1,206 | -804 | -402 | -1,608 | -1,206 |
| Common Stock Issued | 5,180 | 2,258 | 895 | 15,832 | 14,558 |
| Other Financing Activity | 0 | 0 | 0 | -773 | 0 |
| Financing Cash Flow | $3,974 | $1,454 | $493 | $13,451 | $13,352 |
| Beginning Cash Position | 18,120 | 18,120 | 18,120 | 18,400 | 18,400 |
| End Cash Position | 11,006 | 10,895 | 12,723 | 18,120 | 20,266 |
| Net Cash Flow | $-7,114 | $-7,225 | $-5,397 | $-280 | $1,866 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,970 | -8,571 | -5,793 | -12,972 | -10,738 |
| Capital Expenditure | -118 | -108 | -97 | -509 | -381 |
| Free Cash Flow | -11,088 | -8,679 | -5,890 | -13,481 | -11,119 |